Based on available data, adiponectin represents a multifaceted biomarker that may
beneficially affect atherosclerosis, inflammation and insulin resistance pathways. However …

Cardiometabolic diseases encompass those affecting the heart and vasculature as well as
other metabolic problems, such as insulin resistance, diabetes, and non-alcoholic fatty liver …

Basic science studies have shown beneficial effects of adiponectin on glucose homeostasis,
chronic low-grade inflammation, apoptosis, oxidative stress, and atherosclerotic processes …

Abstract Background Elevated triglyceride-glucose (TyG) index and N-terminal pro-B-type
natriuretic peptide (NT-proBNP) are independently associated with increased risk of major …

Metabolic syndrome (MetS) is highly correlated with cardiovascular diseases. Although an
excess of body fat is a determinant factor for MetS development, a reduced level of …

Background Improved heart failure (HF) risk stratification after a recent acute coronary
syndrome may identify those who can benefit from therapies that reduce HF risk. We aimed …

Diabetic cardiomyopathy (DCM) is a severe secondary complication of type 2 diabetes
mellitus (T2DM) that is diagnosed as a heart disease occurring in the absence of any …

Background The associations between the long-term triglyceride-glucose (TyG) index level
and variability and clinical outcomes in patients with acute coronary syndrome (ACS) …

Abstract Dementia, especially Alzheimer's Disease (AD) and vascular dementia, is a major
public health problem that continues to expand in both economically emerging and …

Background: Adiponectin is an adipocyte-derived cytokine closely associated with obesity,
altered body adipose tissue distribution, insulin resistance, and cardiovascular diseases …